Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe ... the company noted. Wegovy was approved as a 2.4mg dose by the US Food and Drug Administration ...

Weight loss drugs like Ozempic and wegovy have become global sensation ... In 2023, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management ...

Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable. In the Phase ...

Weight loss ... be prescribed Wegovy - licensed for weight loss and treating heart disease - for up to two years. But Prof Knudsen said: “These kinds of medicines are approved for lifelong ...

Weight loss jabs such as Wegovy may reduce risk of dementia by easing inflammation in the brain, scientists say. The drugs have been approved for the treatment of obesity and type 2 diabetes ...

SAN FRANCISCO (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for president-elect Donald Trump and Congress on "fixing" a ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...